Cargando…

Non-invasive Brain Stimulation for the Treatment of Gilles de la Tourette Syndrome

Gilles de la Tourette Syndrome is a multifaceted neuropsychiatric disorder typically commencing in childhood and characterized by motor and phonic tics. Its pathophysiology is still incompletely understood. However, there is convincing evidence that structural and functional abnormalities in the bas...

Descripción completa

Detalles Bibliográficos
Autores principales: Kleimaker, Maximilian, Kleimaker, Alexander, Weissbach, Anne, Colzato, Lorenza S., Beste, Christian, Bäumer, Tobias, Münchau, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683779/
https://www.ncbi.nlm.nih.gov/pubmed/33244309
http://dx.doi.org/10.3389/fneur.2020.592258
_version_ 1783612951957078016
author Kleimaker, Maximilian
Kleimaker, Alexander
Weissbach, Anne
Colzato, Lorenza S.
Beste, Christian
Bäumer, Tobias
Münchau, Alexander
author_facet Kleimaker, Maximilian
Kleimaker, Alexander
Weissbach, Anne
Colzato, Lorenza S.
Beste, Christian
Bäumer, Tobias
Münchau, Alexander
author_sort Kleimaker, Maximilian
collection PubMed
description Gilles de la Tourette Syndrome is a multifaceted neuropsychiatric disorder typically commencing in childhood and characterized by motor and phonic tics. Its pathophysiology is still incompletely understood. However, there is convincing evidence that structural and functional abnormalities in the basal ganglia, in cortico-striato-thalamo-cortical circuits, and some cortical areas including medial frontal regions and the prefrontal cortex as well as hyperactivity of the dopaminergic system are key findings. Conventional therapeutic approaches in addition to counseling comprise behavioral treatment, particularly habit reversal therapy, oral pharmacotherapy (antipsychotic medication, alpha-2-agonists) and botulinum toxin injections. In treatment-refractory Tourette syndrome, deep brain stimulation, particularly of the internal segment of the globus pallidus, is an option for a small minority of patients. Based on pathophysiological considerations, non-invasive brain stimulation might be a suitable alternative. Repetitive transcranial magnetic stimulation appears particularly attractive. It can lead to longer-lasting alterations of excitability and connectivity in cortical networks and inter-connected regions including the basal ganglia through the induction of neural plasticity. Stimulation of the primary motor and premotor cortex has so far not been shown to be clinically effective. Some studies, though, suggest that the supplementary motor area or the temporo-parietal junction might be more appropriate targets. In this manuscript, we will review the evidence for the usefulness of repetitive transcranial magnetic stimulation and transcranial electric stimulation as treatment options in Tourette syndrome. Based on pathophysiological considerations we will discuss the rational for other approaches of non-invasive brain stimulation including state informed repetitive transcranial magnetic stimulation.
format Online
Article
Text
id pubmed-7683779
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-76837792020-11-25 Non-invasive Brain Stimulation for the Treatment of Gilles de la Tourette Syndrome Kleimaker, Maximilian Kleimaker, Alexander Weissbach, Anne Colzato, Lorenza S. Beste, Christian Bäumer, Tobias Münchau, Alexander Front Neurol Neurology Gilles de la Tourette Syndrome is a multifaceted neuropsychiatric disorder typically commencing in childhood and characterized by motor and phonic tics. Its pathophysiology is still incompletely understood. However, there is convincing evidence that structural and functional abnormalities in the basal ganglia, in cortico-striato-thalamo-cortical circuits, and some cortical areas including medial frontal regions and the prefrontal cortex as well as hyperactivity of the dopaminergic system are key findings. Conventional therapeutic approaches in addition to counseling comprise behavioral treatment, particularly habit reversal therapy, oral pharmacotherapy (antipsychotic medication, alpha-2-agonists) and botulinum toxin injections. In treatment-refractory Tourette syndrome, deep brain stimulation, particularly of the internal segment of the globus pallidus, is an option for a small minority of patients. Based on pathophysiological considerations, non-invasive brain stimulation might be a suitable alternative. Repetitive transcranial magnetic stimulation appears particularly attractive. It can lead to longer-lasting alterations of excitability and connectivity in cortical networks and inter-connected regions including the basal ganglia through the induction of neural plasticity. Stimulation of the primary motor and premotor cortex has so far not been shown to be clinically effective. Some studies, though, suggest that the supplementary motor area or the temporo-parietal junction might be more appropriate targets. In this manuscript, we will review the evidence for the usefulness of repetitive transcranial magnetic stimulation and transcranial electric stimulation as treatment options in Tourette syndrome. Based on pathophysiological considerations we will discuss the rational for other approaches of non-invasive brain stimulation including state informed repetitive transcranial magnetic stimulation. Frontiers Media S.A. 2020-11-10 /pmc/articles/PMC7683779/ /pubmed/33244309 http://dx.doi.org/10.3389/fneur.2020.592258 Text en Copyright © 2020 Kleimaker, Kleimaker, Weissbach, Colzato, Beste, Bäumer and Münchau. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Kleimaker, Maximilian
Kleimaker, Alexander
Weissbach, Anne
Colzato, Lorenza S.
Beste, Christian
Bäumer, Tobias
Münchau, Alexander
Non-invasive Brain Stimulation for the Treatment of Gilles de la Tourette Syndrome
title Non-invasive Brain Stimulation for the Treatment of Gilles de la Tourette Syndrome
title_full Non-invasive Brain Stimulation for the Treatment of Gilles de la Tourette Syndrome
title_fullStr Non-invasive Brain Stimulation for the Treatment of Gilles de la Tourette Syndrome
title_full_unstemmed Non-invasive Brain Stimulation for the Treatment of Gilles de la Tourette Syndrome
title_short Non-invasive Brain Stimulation for the Treatment of Gilles de la Tourette Syndrome
title_sort non-invasive brain stimulation for the treatment of gilles de la tourette syndrome
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683779/
https://www.ncbi.nlm.nih.gov/pubmed/33244309
http://dx.doi.org/10.3389/fneur.2020.592258
work_keys_str_mv AT kleimakermaximilian noninvasivebrainstimulationforthetreatmentofgillesdelatourettesyndrome
AT kleimakeralexander noninvasivebrainstimulationforthetreatmentofgillesdelatourettesyndrome
AT weissbachanne noninvasivebrainstimulationforthetreatmentofgillesdelatourettesyndrome
AT colzatolorenzas noninvasivebrainstimulationforthetreatmentofgillesdelatourettesyndrome
AT bestechristian noninvasivebrainstimulationforthetreatmentofgillesdelatourettesyndrome
AT baumertobias noninvasivebrainstimulationforthetreatmentofgillesdelatourettesyndrome
AT munchaualexander noninvasivebrainstimulationforthetreatmentofgillesdelatourettesyndrome